2)
There is a good chance that you will recover somewhat or even
completely without treatment. There is also a possibility
that
the stroke can be fatal. We cannot predict how well you will
do.
If we give
this treatment to 100 people:
3) between 12 and 13 would
be better off, recovering to a
less severe degree of persistent disability than would have
happened without treatment.
4) On the other hand, 87 to
88 of the 100 people who receive
this
treatment will not receive any benefit as a result of treatment.
5) About 6 of the 100 people
will be much worse as a result
of treatment and 3 of the 100 will die as a result of receiving
the treatment.
6)
Despite this risk, patients treated with this drug do not have
a higher total death rate and 12 or 13 of the 100 will be better off
as a result of treatment. Nevertheless, the few who have bleeding
complications are definitely worse off.
7)
With or without this treatment you will still continue to
receive all
of
our regular treatment.
8)
The decision is entirely yours. If you choose the treatment,
we
must start right away. Any questions?
Source: Landau WM. Thrombolytic therapy
in acute stroke. Arch Neurol
1998;55:1378.